These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9483472)

  • 1. Neurobiology of panic disorder.
    Bourin M; Baker GB; Bradwejn J
    J Psychosom Res; 1998 Jan; 44(1):163-80. PubMed ID: 9483472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From inducers of panic attack to neurobiology of panic disorder].
    Bourin M
    Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provocative agents in panic disorder.
    Bourin M; Malinge M; Guitton B
    Therapie; 1995; 50(4):301-6. PubMed ID: 7482384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
    Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of Sodium Lactate Infusion and CO2-35% Inhalation for Panic Disorder.
    Wiese AD; Boutros NN
    Neuropsychobiology; 2019; 78(2):59-69. PubMed ID: 30982042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry.
    Sahún I; Gallego X; Gratacòs M; Murtra P; Trullás R; Maldonado R; Estivill X; Dierssen M
    Amino Acids; 2007 Nov; 33(4):677-88. PubMed ID: 17111100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the basolateral amygdala in panic disorder.
    Shekhar A; Sajdyk TS; Keim SR; Yoder KK; Sanders SK
    Ann N Y Acad Sci; 1999 Jun; 877():747-50. PubMed ID: 10415697
    [No Abstract]   [Full Text] [Related]  

  • 9. The biological basis of panic disorder.
    Krystal JH; Deutsch DN; Charney DS
    J Clin Psychiatry; 1996; 57 Suppl 10():23-31; discussion 32-3. PubMed ID: 8917129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis.
    Tural U; Iosifescu DV
    Pharmacopsychiatry; 2022 Mar; 55(2):87-94. PubMed ID: 34666404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to carbon dioxide in subjects with a single lifetime panic attack: possible clinical "bedside" predictive test for panic disorder after a first attack.
    Berzak E; Reznik M; Narsia O; Benjamin J
    Depress Anxiety; 2004; 20(1):48-50. PubMed ID: 15368597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased response to a putative panicogenic nocebo administration in female patients with panic disorder.
    Ströhle A
    J Psychiatr Res; 2000; 34(6):439-42. PubMed ID: 11165311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panic attacks during placebo procedures in the laboratory. Physiology and symptomatology.
    Goetz RR; Klein DF; Gully R; Kahn J; Liebowitz MR; Fyer AJ; Gorman JM
    Arch Gen Psychiatry; 1993 Apr; 50(4):280-5. PubMed ID: 8466389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurobiology of social phobia.
    Potts NL; Book S; Davidson JR
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():43-8. PubMed ID: 8923109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects.
    Papp LA; Martinez JM; Klein DF; Coplan JD; Norman RG; Cole R; de Jesus MJ; Ross D; Goetz R; Gorman JM
    Am J Psychiatry; 1997 Nov; 154(11):1557-65. PubMed ID: 9356564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropharmacological and genetic study of panic disorder].
    Akiyoshi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):93-9. PubMed ID: 10495983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiological investigations into the role of cholecystokinin in panic disorder.
    Bradwejn J
    J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
    Verburg K; Griez E; Meijer J; Pols H
    Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.